​

McKesson (MCK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MCK Stock Forecast

McKesson (MCK) stock forecast, based on 31 Wall Street analysts, predicts a 12-month average price target of $772.00, with a high of $772.00 and a low of $772.00. This represents a 7.25% increase from the last price of $719.80.

$450 $520 $590 $660 $730 $800 High: $772 Avg: $772 Low: $772 Last Closed Price: $719.8

MCK Stock Rating

McKesson stock's rating consensus is Buy, based on 31 Wall Street analysts. The breakdown includes 1 Strong Buy (3.23%), 25 Buy (80.65%), 5 Hold (16.13%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 31 5 25 1 Strong Sell Sell Hold Buy Strong Buy

MCK Price Target Upside V Benchmarks

TypeNameUpside
StockMcKesson7.25%
SectorHealthcare Stocks 13.55%
IndustryMedical Distribution Stocks13.24%

Price Target Trends

1M3M12M
# Anlaysts117
Avg Price Target$772.00$772.00$655.14
Last Closing Price$719.80$719.80$719.80
Upside/Downside7.25%7.25%-8.98%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 252104--16
Aug, 252103-116
Jul, 253103-117
Jun, 253103-117
May, 253103-117
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 13, 2025Stephen BaxterWells Fargo$772.00$659.0117.15%7.25%
Jun 03, 2025Stephen BaxterWells Fargo$766.00$714.887.15%6.42%
Nov 19, 2024Rob DickersonJefferies$715.00$541.1532.13%-0.67%
Nov 07, 2024Eric ColdwellRobert W. Baird$688.00$526.5430.66%-4.42%
Sep 25, 2024George HillDeutsche Bank$579.00$479.1620.84%-19.56%
Sep 24, 2024Eric ColdwellRobert W. Baird$531.00$505.005.15%-26.23%
Sep 13, 2024Stephen BaxterWells Fargo$535.00$511.174.66%-25.67%
Sep 06, 2024Michael ChernyLeerink Partners$665.00$514.7529.19%-7.61%
Sep 05, 2024Michael ChernyBank of America Securities$635.00$526.5020.61%-11.78%
Aug 08, 2024Ann HynesMizuho Securities$570.00$617.51-7.69%-20.81%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 07, 2025Cowen & Co.BuyBuyhold
Jul 16, 2025Morgan StanleyOverweightOverweighthold
Nov 19, 2024JefferiesBuyBuyhold
Oct 01, 2024BarclaysPositivePositivehold
Sep 25, 2024Deutsche BankBuyBuyhold
Sep 24, 2024WedbushNeutraldowngrade
Sep 23, 2024JefferiesHoldHoldhold
Sep 13, 2024Wells FargoEqual-WeightEqual-Weighthold
Sep 06, 2024Leerink PartnersOutperformOutperformhold
Sep 05, 2024Bank of America SecuritiesBuyBuyhold

Financial Forecast

EPS Forecast

$-30 $-12 $6 $24 $42 $60 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$-27.02$7.31$25.23$22.54-----
Avg Forecast$17.23$23.89$25.96$27.61$32.69$36.82$41.28$46.94$53.78
High Forecast$17.68$24.51$26.88$27.95$32.97$37.67$43.85$48.61$55.70
Low Forecast$16.74$23.20$25.16$27.47$32.40$35.56$35.30$45.51$52.14
Surprise %-256.82%-69.40%-2.81%-18.36%-----

Revenue Forecast

$200B $270B $340B $410B $480B $550B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$238.23B$263.97B$276.71B$308.95B-----
Avg Forecast$240.05B$260.88B$275.91B$311.92B$360.18B$396.03B$424.30B$464.80B$517.85B
High Forecast$244.87B$266.13B$283.48B$312.88B$362.60B$412.08B$425.21B$477.55B$532.05B
Low Forecast$234.74B$255.12B$269.43B$309.58B$357.80B$382.12B$423.39B$453.88B$505.68B
Surprise %-0.76%1.18%0.29%-0.95%-----

Net Income Forecast

$-10B $-6B $-2B $2B $6B $10B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29
Reported$-4.34B$1.11B$3.56B$3.00B-----
Avg Forecast$-3.74B$1.15B$3.48B$3.00B$4.38B$4.91B$5.31B$6.29B$7.21B
High Forecast$-2.28B$1.39B$3.60B$3.60B$4.42B$5.05B$5.88B$6.52B$7.47B
Low Forecast$-5.20B$919.44M$3.37B$2.39B$4.34B$4.77B$4.73B$6.10B$6.99B
Surprise %15.99%-3.33%2.28%0.13%-----

MCK Forecast FAQ

Is McKesson stock a buy?

McKesson stock has a consensus rating of Buy, based on 31 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 25 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that McKesson is a favorable investment for most analysts.

What is McKesson's price target?

McKesson's price target, set by 31 Wall Street analysts, averages $772 over the next 12 months. The price target range spans from $772 at the low end to $772 at the high end, suggesting a potential 7.25% change from the previous closing price of $719.8.

How does McKesson stock forecast compare to its benchmarks?

McKesson's stock forecast shows a 7.25% upside, underperforming the average forecast for the healthcare stocks sector (13.55%) and underperforming the medical distribution stocks industry (13.24%).

What is the breakdown of analyst ratings for McKesson over the past three months?

  • September 2025: 12.50% Strong Buy, 62.50% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 12.50% Strong Buy, 62.50% Buy, 18.75% Hold, 0% Sell, 6.25% Strong Sell.
  • July 2025: 17.65% Strong Buy, 58.82% Buy, 17.65% Hold, 0% Sell, 5.88% Strong Sell.

What is McKesson’s EPS forecast?

McKesson's average annual EPS forecast for its fiscal year ending in March 2025 is $32.69, marking a 45.03% increase from the reported $22.54 in 2024. Estimates for the following years are $36.82 in 2026, $41.28 in 2027, $46.94 in 2028, and $53.78 in 2029.

What is McKesson’s revenue forecast?

McKesson's average annual revenue forecast for its fiscal year ending in March 2025 is $360.18B, reflecting a 16.58% increase from the reported $308.95B in 2024. The forecast for 2026 is $396.03B, followed by $424.3B for 2027, $464.8B for 2028, and $517.85B for 2029.

What is McKesson’s net income forecast?

McKesson's net income forecast for the fiscal year ending in March 2025 stands at $4.38B, representing an 45.98% increase from the reported $3B in 2024. Projections indicate $4.91B in 2026, $5.31B in 2027, $6.29B in 2028, and $7.21B in 2029.